FDA Approved: LATISSE — Original Application (Allergan, Inc.)

View source ↗

Summary

FDA approved LATISSE (bimatoprost) from Allergan for the treatment of hypotrichosis of the eyelashes to promote eyelash growth.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypotrichosis of the Eyelashes

Drugs mentioned

• LATISSE (BIMATOPROST)

Snippet

ORIG AP for LATISSE (BIMATOPROST)